company insight

Pall Biotech

There are many ways to achieve your production goals. We’ll support you with technologies, knowledge and service all the way. Whether you take a traditional or single-use batch manufacturing approach, want to explore continuous processing, or develop a hybrid solution, our broad portfolio and specialist biotech support services will get you to your destination.

As the demand for commercialized monoclonal antibody and recombinant protein based therapies continues to grow, the strength of the development pipeline only accelerates this growth.

Robust and economic manufacturing approaches support rising production values and the increasing number of therapies at all stages of development and clinical manufacture.  

There is no one universal manufacturing solution. 

Whether you are developing an entire process or just one unit operation there are many ways to reach your bioprocessing goals. Which way should you go? 

Pall Biotech’s versatile bioprocessing product portfolio provides class leading expertise, technology and integrated solutions to support every step of your journey. 

Whether your preference is for traditional methods, the adoption of single-use technology or continuous bioprocessing – Pall gives you the freedom to choose your way. 

Every choice of manufacturing technology gives you access to improvements in productivity, agility and economy. 

Whatever direction you choose only Pall Biotech can provide true flexibility with innovative technologies, integrated solutions, process development and engineering and scientific support at every stage from planning through platform to final production.  

Whatever your biotech journey:

  • Innovative products
  • Integrated solutions
  • Engineering and scientific support

Whether you are developing an entire process or just one unit operation there are many ways to reach your bioprocessing goals. 

Pall Biotech’s versatile bioprocessing product portfolio provides class leading expertise, technology and integrated solutions to support every step of your journey.

From upstream to downstream, through to formulation and filling, our portfolio enables rapid development and implementation of scalable processes from pre-clinical to cGMP commercial manufacturing, facilitating the industrialization and evolution of bioprocesses. Our global structure delivers local support and engineering expertise with a collaborative, cost-effective approach to bioprocessing.

Innovative products:

Pall Biotech’s product portfolio is extensive and complete, allowing us to deliver solutions for all the unit operations steps from upstream through downstream, to final formulation and filling, using batch, fed-batch or continuous processing. This ensures continuity and compatibility of materials and equipment, simplifying validation and qualification processes.

Integrated solutions:

Our integrated solutions team combines best engineering and project management practices with an in depth industry knowledge and diverse equipment portfolio to combine multiple unit operations into a single, centrally automated process which is delivered on time and on budget, ready for when you need it. 

Engineering and Scientific Support:

We have a team of over 200 engineers based in 13 countries who can work with you to develop your system solution and meet your process requirements.  Our team of over 270 scientists based in 6 hubs around the world, provide integrated global technical support, from process development, validation and qualification, through to operator training.

Your Biotech Journey. Your Choice.

caption

Contact information:

Pall Biotech

Go to top

Share this article

Go to article: Home | The Dawn of Big DataGo to article: EditorialGo to article: Scandinavian Health Ltd. Company InsightGo to article: Scandinavian Health Ltd.Go to article: ContentsGo to article: Daiichi JitsugyoGo to article: How will Amazon's acquisition of online pharmacy business PillPack disrupt the pharmaceutical industry? Go to article: HOF Sonderanlagenbau Company InsightGo to article: HOF SonderanlagenbauGo to article: Fentanyl: where did it all go wrong?Go to article: NSFGo to article: Komtur Pharmaceuticals Company InsightGo to article: Komtur PharmaceuticalsGo to article: Turning up the heat on nano researchGo to article: TSS Company InsightGo to article: TSS ABGo to article: MedelpharmGo to article: Cracking the mystery of Alzheimer's diseaseGo to article: Röchling Medical NeuhausGo to article: International Cannabis and Cannabinoid Institute (ICCI) Company InsightGo to article: International Cannabis and Cannabinoid Institute (ICCI)Go to article: Where are the world's pharma manufacturing hotspots?Go to article: Gerteis Company InsightGo to article: GerteisGo to article: ZenatekGo to article: How India’s use of unapproved antibiotics could undermine global healthGo to article: Novo Nordisk PharmatechGo to article: Phoenix Company InsightGo to article: PhoenixGo to article: CRISPR: a seismic shift in gene editingGo to article: CBDepot Company InsightGo to article: CBDepotGo to article: Is the UK’s drug evaluation system in need of an overhaul?Go to article: Nelson Labs Company InsightGo to article: Nelson LabsGo to article: Centaur Clinical | Company InsightGo to article: Centaur ClinicalGo to article: Opening up the Chinese drug marketGo to article: Finnair Cargo | Company InsightGo to article: Finnair CargoGo to article: Immunising against opioids – could a vaccine solve the crisis? Go to article: Molnar Company InsightGo to article: MolnarGo to article: PharmasolGo to article: The next generation of antimalarials Go to article: Oncology Therapeutic Development Company InsightGo to article: Oncology Therapeutic DevelopmentGo to article: Pharma Support Services Company InsightGo to article: Pharma Support ServicesGo to article: The People vs Big Pharma: tackling the industry’s trust issuesGo to article: G.F.Go to article: Pfanstiehl Company InsightGo to article: PfanstiehlGo to article: Amazon and PillPack: an unstoppable pharmacy force?Go to article: BEAGo to article: Buchi Labortechnik AG Company InsightGo to article: Buchi Labortechnik AGGo to article: Is the microbiome as important for precision medicine as genetics?Go to article: Medical HempGo to article: Senn ChemicalsGo to article: Senn ChemicalsGo to article: Niconex Medical LtdGo to article: HPV vaccines: a decade of progressGo to article: Med-Script AssociatesGo to article: B&W Tek | Company InsightGo to article: B&W TekGo to article: EventsGo to article: CG ChemikalienGo to article: AlpexGo to article: Next issueGo to article: Pall Biotech Company InsightGo to article: CrewpharmGo to article: EndocaGo to article: Diversey